bioRxivImmunologyPreprint
Temporal profiling of human lymphoid tissues reveals coordinated defence to viral challenge
M. L. Coates, N. Richoz, Z. K. Tuong, G. Bowyer, C. Y. C. Lee, J. R. Ferdinand, E. Gillman, M. McClure, R. Di Marco Barros, B. J. Stewart, M. R. Clatworthy
Abstract
Adaptive immunity is generated in lymphoid organs, but how these structures defend themselves during infection in humans is unknown. The nasal epithelium is a major site of viral entry, with adenoid nasal-associated lymphoid tissue (NALT) generating early adaptive responses. Here, using a nasopharyngeal biopsy, we examined longitudinal immune responses in NALT following viral challenge, using SARS-CoV-2 infection as a natural experimental model. In acute infection, infiltrating monocytes formed a subepithelial and peri-follicular shield, recruiting NET-forming neutrophils, whilst tissue macrophages expressed pro-repair molecules during convalescence to promote the restoration of tissue integrity. Germinal centre B cells expressed anti-viral transcripts that inversely correlated with fate-defining transcription factors. Among T cells, tissue-resident memory CD8 T cells alone showed clonal expansion and maintained cytotoxic transcriptional programmes into convalescence. Together our study provides a unique insight into how human nasal adaptive immune responses are generated and sustained in the face of viral challenge.
- organism: human
- assay: bulk RNA-seq
- research focus: host-pathogen & immune response
- research focus: cell type annotation
- research focus: differential expression
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Coordinated immune-epithelial dynamics in the nasal epithelium protect against respiratory virus infection
Yao Yu Yeo, Hsin‐Yi Chen, … Sizun Jiang·bioRxiv·Jun 9, 2026
- Human nasal and lung tissues infected ex vivo with SARS-CoV-2 provide insights into differential tissue-specific and virus-specific innate immune responses in the upper and lower respiratory tract
O. Alfi, A. Yakirevich, … D. G. Wolf·bioRxiv·Mar 8, 2021
- Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2
C. F. Hatton, R. A. Botting, … C. J. A. Duncan·bioRxiv·Feb 17, 2021
- Primary nasal viral infection rewires the tissue-scale memory response
S. W. Kazer, C. M. Match, … J. Ordovas-Montanes·bioRxiv·May 11, 2023
- Disruption of nasal bacteria enhances protective immune responses to influenza A virus and SARS-CoV-2 infection in mice
M. Nagai, M. Moriyama, T. Ichinohe·bioRxiv·Dec 25, 2020
- Utility of nasal swabs for assessing mucosal immune responses towards SARS-CoV-2
E. K. Roubidoux, P. H. Brigleb, … S. Schultz-Cherry·bioRxiv·Jul 12, 2023